logo
Share SHARE
FONT-SIZE Plus   Neg

Arca Continental Q1 Profit Rises

Coca-Cola bottler Arca Continental, S. A. B. de C. V. (EMBVF.PK) Friday posted higher net profit for the first quarter reflecting increased revenue for the period, primarily led by a sales rise in North America.

For the quarter, the company reported net income of 1.09 billion peso, up 11.3 percent from 979 million peso last year.

Revenue for the quarter was 13.375 billion peso, up 8.3 percent from 12.35 billion peso a year back. Net sales in North America for the quarter was 9.989 billion peso, up from 9.144 billion peso last year.

Commenting on the results, Francisco Egloff, CEO of Arca Continental said, "During the first quarter of 2013 we continued to focus on satisfying our clients and consumers while increasing the efficiency of our operations, which translated into improved profitability with EBITDA up 16.8 percent versus last year. The actions that had the most impact were the optimization of our pricing structure, cost improvements and perfecting our execution at the point of sale; combined, these steps enabled us increase our market share and strengthen our leading position in the various categories and territories in which we participate."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT